Release according to Article 111c of the German Stock Corporation Act (AktG) with the objective of Europe-wide distribution

DEMIRE signs shareholder loan previously announced for the financing of its planned cash tender offer for bonds and the related backstop as part of the restructuring of its 2019/2024 bond

Langen, 24 September 2024. Today, DEMIRE Deutsche Mittelstand Real Estate AG (ISIN: DE000A0XFSF0) ("Company") with the approval of the supervisory board signed an agreement with AEPF III 15 S.à r.l. (the "Shareholder"), a subsidiary of certain funds managed by affiliates of Apollo Global Management, Inc., on granting an unsecured subordinated shareholder loan to the Company ("Shareholder Loan"). The Company has agreed that the claims related to the Shareholder Loan can be partially assigned and transferred by way of assumption of contract (Vertragsübernahme) to Care4 AG, a company belonging to the Wecken group. The Shareholder and Wecken group together currently hold 90.75% of the voting rights in the Company. The voting rights directly held by the Shareholder and the Wecken group continue to be attributed reciprocally (acting in concert).

The Shareholder Loan is part of the restructuring of the bond issued by the Company (ISIN: DE000A2YPAK1) with a maturity date of October 15, 2024, and a currently outstanding principal amount of EUR 499 million ("Bond") published in the Company's ad hoc announcement dated June 5, 2024. The Shareholder Loan can be utilized by the Company in any amount between EUR 68,345,000.00 and EUR 100,000,000.00 to partially fund the envisaged cash tender offer for the Bond and the related backstop. The Shareholder Loan is due for repayment on the earlier of (i) the first anniversary of the date on which the Bonds have been redeemed in full and (ii) 31 December 2028. Interests amount to 22% per annum and shall be payable in cash on a half-yearly basis unless the Company elects to capitalize the respective accrued interest. Further, the Company can utilize the Shareholder Loan in an additional amount of up to EUR 5,000,000.00 to fund the agreed reimbursement of the Shareholder for its third-party costs and expenses.